Mark Stenhouse to join Exact Sciences as President, Cologuard

Harry Connick, Jr. and Wife and Cancer Survivor Jill Connick Team Up to Urge People 50 and Older to Get Screened for Colon Cancer

Exact Sciences to report $265.5-266.5 million in revenue, 168 percent growth for 2017

For the Second Consecutive Year, Exact Sciences included in Deloitte’s Technology Fast 500.

Cologuard's Patient Compliance Program

Exact Sciences to Expand Laboratory and Corporate Facilities in Madison

PGA TOUR Champions and Exact Sciences announce Cologuard Classic as new title of Tucson event

Meet the people behind Cologuard: #TeamCologuard

Cologuard® revenue increased 158 percent to $73 million during third quarter

Grand Prize Winners of Packers-Cologuard Colon Cancer Awareness Campaign Announced

Green Bay Packers and Cologuard Launch Colon Cancer Awareness Campaign

Cologuard® revenue increased to $57.6 million during second quarter; Test volume grew 149 percent from second quarter of 2016 to 135,000 completed tests